| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 14,734 | 13,634 | 13,800 | 16,477 | | Cost of Revenue | 4,358 | 4,290 | 4,512 | 6,148 | | | Gross Profit | 10,376 | 9,344 | 9,288 | 10,329 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 7,201 | 6,112 | 6,687 | 5,683 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 1,002 | 863 | 1,037 | 1,023 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 611 | 2,369 | 1,564 | 3,623 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 990 | 951 | 726 | (5,704) | | Earnings Before Interest And Taxes | 3,163 | 3,320 | 2,290 | (2,081) | | Interest Expense | 510 | 520 | 532 | 2,115 | | Income Before Tax | 2,653 | 2,800 | 1,758 | (4,196) | | Income Tax Expense | 1,027 | 1,040 | 641 | (1,062) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,626 | 1,760 | 1,117 | (3,134) | | | Non-recurring Events | | Discontinued Operations | (447) | (524) |
-
| 6,583 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,593 | 1,236 | 1,117 | 3,449 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,593 | $1,236 | $1,117 | $3,449 |
|
0.51% Nasdaq 
Income Statement
